joachim widder

Summary

Affiliation: University Medical Center Groningen
Location: , Netherlands

Publications

  1. doi Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study)
    Coen W Hurkmans
    Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
    Int J Radiat Oncol Biol Phys 80:918-27. 2011
  2. ncbi Impaired quality of life in patients commencing radiotherapy for cancer
    Monika Janda
    Department of Radiotherapy and Radiobiology, Medical School, University of Vienna, General Hospital, Vienna, Austria
    Strahlenther Onkol 180:78-83. 2004
  3. ncbi Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al
    Cohen W Hurkmans
    Int J Radiat Oncol Biol Phys 75:318; author reply 318. 2009
  4. doi Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation
    Joachim Widder
    Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P O Box 30 001, 9700RB Groningen, The Netherlands
    Radiother Oncol 94:42-6. 2010
  5. doi Vienna international summer school on experimental and clinical oncology for medical students: an Austrian cancer education project
    Sabine Fromm-Haidenberger
    Institute of Radiology, LKH Gmunden, Miller v Aichholzstrasse 49, 4810, Gmunden, Austria
    J Cancer Educ 25:51-4. 2010
  6. doi Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study
    G Spizzo
    Division of Haematology and Oncology, Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria
    Ann Surg Oncol 18:677-83. 2011
  7. pmc 18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study
    Erwin M Wiegman
    Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Eur J Nucl Med Mol Imaging 38:1059-63. 2011
  8. doi 18F-FLT-PET for detection of rectal cancer
    Christina T Muijs
    Department of Radiation Oncology, University Medical Center Groningen, The Netherlands
    Radiother Oncol 98:357-9. 2011
  9. doi Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer
    Joachim Widder
    Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Int J Radiat Oncol Biol Phys 81:e291-7. 2011
  10. doi Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
    Jean Pierre Pignon
    Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
    Radiother Oncol 92:4-14. 2009

Detail Information

Publications21

  1. doi Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study)
    Coen W Hurkmans
    Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
    Int J Radiat Oncol Biol Phys 80:918-27. 2011
    ..To determine the accuracy of four-dimensional computed tomography (4D-CT) scanning techniques in institutions participating in a Phase III trial of surgery vs. stereotactic radiotherapy (SBRT) for lung cancer...
  2. ncbi Impaired quality of life in patients commencing radiotherapy for cancer
    Monika Janda
    Department of Radiotherapy and Radiobiology, Medical School, University of Vienna, General Hospital, Vienna, Austria
    Strahlenther Onkol 180:78-83. 2004
    ....
  3. ncbi Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al
    Cohen W Hurkmans
    Int J Radiat Oncol Biol Phys 75:318; author reply 318. 2009
  4. doi Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation
    Joachim Widder
    Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P O Box 30 001, 9700RB Groningen, The Netherlands
    Radiother Oncol 94:42-6. 2010
    ..To define a method of dose prescription employing Monte Carlo (MC) dose calculation in stereotactic body radiotherapy (SBRT) for lung tumours aiming at a dose as low as possible outside of the PTV...
  5. doi Vienna international summer school on experimental and clinical oncology for medical students: an Austrian cancer education project
    Sabine Fromm-Haidenberger
    Institute of Radiology, LKH Gmunden, Miller v Aichholzstrasse 49, 4810, Gmunden, Austria
    J Cancer Educ 25:51-4. 2010
    ..The summer school has a high degree of acceptance and is a very useful tool to teach medical students about oncology and approaching a cancer patient...
  6. doi Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study
    G Spizzo
    Division of Haematology and Oncology, Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria
    Ann Surg Oncol 18:677-83. 2011
    ..We conducted a phase II feasibility study using preoperative chemotherapy with cisplatin and docetaxel followed by surgical resection and postoperative chemoradiation in patients with gastric or gastroesophageal cancer...
  7. pmc 18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study
    Erwin M Wiegman
    Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Eur J Nucl Med Mol Imaging 38:1059-63. 2011
    ..However, whether a metabolic response can be observed already during treatment and thus can be used to predict treatment outcome is undetermined...
  8. doi 18F-FLT-PET for detection of rectal cancer
    Christina T Muijs
    Department of Radiation Oncology, University Medical Center Groningen, The Netherlands
    Radiother Oncol 98:357-9. 2011
    ....
  9. doi Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer
    Joachim Widder
    Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Int J Radiat Oncol Biol Phys 81:e291-7. 2011
    ....
  10. doi Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
    Jean Pierre Pignon
    Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
    Radiother Oncol 92:4-14. 2009
    ..However the heterogeneity of the results limited the conclusions and prompted us to confirm the results on a more complete database by adding the randomised trials conducted between 1994 and 2000...
  11. pmc Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study
    Coen W Hurkmans
    Department of Radiation Therapy, Catharina Hospital, Eindhoven, The Netherlands
    Radiat Oncol 4:1. 2009
    ..Due to rapid changes in radiotherapy technology and evolving techniques for image-guided delivery, guidelines had to be developed in order to ensure uniformity in implementation of stereotactic radiotherapy in this multi-centre study...
  12. pmc Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
    T Brodowicz
    Clinical Division of Oncology Vienna Austria
    Sarcoma 4:151-60. 2000
    ....
  13. ncbi The origins of medical evidence: communication and experimentation
    Joachim Widder
    Dept of Radiotherapy and Radiobiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Med Health Care Philos 7:99-104. 2004
    ....
  14. ncbi Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancer
    J Widder
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Radiother Oncol 73:173-7. 2004
    ..This treatment is at the edge of local tolerability, but there is a good curative chance even for very advanced localised tumours, provided a complete remission is induced at primary treatment...
  15. ncbi [Revolution of disease concept through pathologic-anatomical thinking and its broadening in future medical research]
    Joachim Widder
    Universitätsklinik für Strahlentherapie, AKH Medizinische Universität, Wien, Osterreich
    Wien Klin Wochenschr 116:804-7. 2004
  16. pmc Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)
    J Widder
    Department of Radiotherapy and Radiobiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Br J Cancer 92:1209-14. 2005
    ..Bowel function was satisfactory after more than 5 years. Local control in primarily resectable rectal cancer after 10 x 2.5 Gy is excellent, warranting further evaluation of this treatment...
  17. ncbi Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer
    Joachim Widder
    Acta Oncol 44:921-3. 2005
  18. ncbi [Who makes decisions--the dilemma of decision-making within the framework of job-sharing in a hospital]
    Elisabeth Voglmayr
    Palliativstation des Krankenhauses der Elisabethinen, Linz, Osterreich
    Wien Med Wochenschr 156:314-7. 2006
    ..A possible solution to such a complex problem will be the introduction of ethical case deliberation...
  19. ncbi Post hoc, ergo propter hoc. In regard to Fietkau et al. (Int J Radiat Oncol Biol Phys 2007;67:1008-1019)
    Joachim Widder
    Int J Radiat Oncol Biol Phys 68:1581; author reply 1580-1. 2007
  20. doi Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients
    Joachim Widder
    Department of Radiotherapy, Medical University of Vienna, Austria
    Radiother Oncol 87:367-75. 2008
    ..To retrospectively analyse a large consecutive cohort of patients with anal cancer for treatment-related factors influencing local control and survival...
  21. ncbi Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
    Joachim Widder
    Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
    Radiother Oncol 107:409-13. 2013
    ..We analysed consecutive patients referred via a university-hospital based multidisciplinary team...